93 related articles for article (PubMed ID: 1103673)
21. Effect of 5-azacytidine treatment on mouse embryonal carcinoma cells.
Cremisi C
J Cell Physiol; 1983 Aug; 116(2):181-90. PubMed ID: 6190823
[TBL] [Abstract][Full Text] [Related]
22. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
Chuĭkin IA; Lianguzova MS; Pospelov VA
Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric analysis of the effect 5-bromodeoxyuridine on mouse teratocarcinoma cells.
Swartzendruber DE; Travis GL; Martin JC
Cytometry; 1980 Nov; 1(3):238-44. PubMed ID: 7021106
[TBL] [Abstract][Full Text] [Related]
24. Multiple splenic lymphoid cell subpopulations regulate H-2 antigen expression on teratocarcinoma cells in vivo.
Ostrand-Rosenberg S; Cohn AL; Sandoz JW
J Immunol; 1983 Jun; 130(6):2969-73. PubMed ID: 6133895
[TBL] [Abstract][Full Text] [Related]
25. Human teratocarcinoma stem cells: glycolipid antigen expression and modulation during differentiation.
Andrews PW
J Cell Biochem; 1987 Dec; 35(4):321-32. PubMed ID: 3326883
[TBL] [Abstract][Full Text] [Related]
26. Delayed activation of HNF-3 beta upon retinoic acid-induced teratocarcinoma cell differentiation.
Reichel RR; Budhiraja S; Jacob A
Exp Cell Res; 1994 Oct; 214(2):634-41. PubMed ID: 7925656
[TBL] [Abstract][Full Text] [Related]
27. Blood formation in a clonal cell line of mouse teratocarcinoma.
Cudennec C; Nicolas JF
J Embryol Exp Morphol; 1977 Apr; 38():203-10. PubMed ID: 886245
[TBL] [Abstract][Full Text] [Related]
28. Developmental characteristics of somatic cell hybrids between totipotent mouse teratocarcinoma and rat intestinal villus cells.
van der Kamp AW; Roza-de Jongh EJ; Houwen RH; Magrane GG; van Dongen JM; Evans MJ
Exp Cell Res; 1984 Sep; 154(1):53-64. PubMed ID: 6381077
[TBL] [Abstract][Full Text] [Related]
29. In vivo diffusion chamber culture reduces the tumorigenicity of PCC4-aza1 teratocarcinoma cells.
Nomura T; Kameyama T
Cancer Lett; 1987 Jan; 34(1):21-6. PubMed ID: 3802066
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the F9 antigen(s) isolated from teratocarcinoma cell culture medium.
McCormick PJ; Dimeo A; Neuner E; Artzt K
Cell Differ; 1982 May; 11(3):135-40. PubMed ID: 7116455
[TBL] [Abstract][Full Text] [Related]
31. Primitive teratocarcinoma cells express a differentiation antigen specified by a gene at the T-locus in the mouse.
Artzt K; Bennett D; Jacob F
Proc Natl Acad Sci U S A; 1974 Mar; 71(3):811-4. PubMed ID: 4522792
[TBL] [Abstract][Full Text] [Related]
32. Immunochemical characterization of surface antigens of TerC, a teratocarcinoma-derived cell line.
Larraga V; Edidin M
Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2912-6. PubMed ID: 379868
[TBL] [Abstract][Full Text] [Related]
33. Relationship of F9 antigens to spermatogenic cell antigens.
Vojtísková M; Dráber P; Pokorná Z
Cell Differ; 1984 Dec; 15(2-4):185-8. PubMed ID: 6152580
[TBL] [Abstract][Full Text] [Related]
34. Mouse teratocarcinoma. Carbon source utilization patterns for growth and in vitro differentiation.
Avner P; Dubois P; Nicolas JF; Jakob H; Gaillard J; Jacob F
Exp Cell Res; 1977 Mar; 105(1):39-50. PubMed ID: 138595
[No Abstract] [Full Text] [Related]
35. Embryoid bodies cultured in in vivo diffusion chambers show reduced tumorigenicity while retaining expression of F9 antigens.
Nomura T; Satoh N; Kameyama T
Exp Cell Res; 1984 Aug; 153(2):506-14. PubMed ID: 6734753
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a xenogeneic antiserum raised against the fetal germ cells of the mouse: cross-reactivity with embryonal carcinoma cells.
Heath JK
Cell; 1978 Sep; 15(1):299-306. PubMed ID: 359167
[TBL] [Abstract][Full Text] [Related]
37. PCC4azal teratocarcinoma stem cell differentiation in culture. I. Biochemical studies.
Lo CW; Gilula NB
Dev Biol; 1980 Mar; 75(1):78-92. PubMed ID: 7371997
[No Abstract] [Full Text] [Related]
38. Effects of anti-embryonal carcinoma serum on aggregation and metabolic cooperation between teratocarcinoma cells.
Nicolas JF; Kemler R; Jacob F
Dev Biol; 1981 Jan; 81(1):127-32. PubMed ID: 6257575
[No Abstract] [Full Text] [Related]
39. Localization of H blood group antigen in ectoblastic derivatives of murine teratocarcinoma.
Trojan J; Gaillard J; Vedrenne C; Roland J; Mollicone R; Oriol R
Tumour Biol; 1987; 8(1):9-18. PubMed ID: 3299661
[TBL] [Abstract][Full Text] [Related]
40. The potential usefulness of a differentiating teratocarcinoma cell line in in vitro toxicity testing.
Hulme LM; Atkinson KA; Clothier RH; Balls M
Toxicol In Vitro; 1990; 4(4-5):589-92. PubMed ID: 20702235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
